Home
Categories
Ingredients
Research & Development
Manufacturing
Packaging
Active Nutrition
Cardiovascular
Digestion
Cognitive
Finance
Regulatory
Company News
Events
Directory
Search
Close search
Home
Diapharm
Diapharm
Activities:
Regulatory
Pharmaceutical
X
LinkedIn
Trending Articles
Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight
Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight
Anthocyanin nanoencapsulation boosts the nutraceutical's absorbency in the gut, study reveals
Nanoencapsulation has been shown to prevent the premature degradation of anthocyanins in the gut, while also enhancing its bioavailability and efficacy as an anti-inflammatory...
Mythbusting study highlights the heart health benefits of omega-6 fatty acids
A new report has highlighted the benefits of omega-6 intake — specifically linoleic acid — in reducing the risk of cardiovascular disease, type II diabetes and elevated...
Synbiotic combination boosts heart health for those with metabolic syndrome, study finds
A nutraceutical containing both prebiotics and probiotics has been found to significantly reduce both gut and cardiovascular inflammation in an animal model of metabolic syndrome
Rousselot
Rousselot offers a comprehensive range of premium products and solutions, from functional gelatins to collagen peptides. Our expertise enables us to assist you in designing...
Upcoming event
Vitafoods India
5–7 February 2025 | Exhibition | Mumbai
See all
Related Content
Ingredients
Bladderwrack weight loss remedy gets first German approval
German regulatory body has granted Diapharm the registration for seaweed powder to complement a weight loss diet
Ingredients
Natural medicinal products against menstrual complaints
Yarrow and Shepherd’s purse registered with the BfArM
Regulatory
Diapharm fortifies its ties with China
Successful scientific advice for first ‘full application’ TCM in Europe
Finance
SU BioMedicine and Diapharm collaborate to register and market high quality Chinese medicines in Europe
New venture will support the unmet medical/societal need for cure and care products for personalised health strategies
Subscribe now